Thank you for agreeing to participate in this survey.
You have been chosen for this Conditional License Program because we respect your opinion and expertise in the field of veterinary dermatology. Your valuable feedback will help us gather important clinical information and allow us to be better prepared when we launch this new biotherapeutic to the entire veterinary community.
Once you have administered Canine Atopic Dermatitis Immunotherapeutic* to several patients, please provide us with feedback about your experience below.
ALL FIELDS IN BOLD ARE REQUIRED.